IP Library Patent Application 11130018
Patent Application
App. No. 11/130,018

Chemical cleaning of biological material

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/130,018
Abstract

The invention is directed to collagenous tissues which have been treated to remove non-collagenous components such as cells, cellular debris, and other extracellular matrix components, such as proteoglycans and glycosaminoglycans, normally found in native tissues. Treatment of the tissue with alkali, chelating agents, acids and salts removes non-collagenous components from the collagenous tissue matrix while controlling the amount of swelling and dissolution so that the resultant collagen matrix retains its structural organization, integrity and bioremodelable properties. The process circumvents the need to use detergents and enzymes which detrimentally affect the cell compatibility, strength and bioremodelability of the collagen matrix. The collagenous tissue matrix is used for implantation, repair, or use in a mammalian host.

Claims (16)

1 . A bioremodelable collagenous tissue matrix composition derived from native tissue, comprising:

telopeptide collagen;

elastin, wherein elastin is less than 10% of the total composition based on dry weight; and

non-collagenous and non-elastinous components, wherein said components are less than 5% of the total composition based on dry weight;

wherein the collagenous tissue matrix is free of detergent residues, enzymatic modification, endotoxin and cells and cellular debris; and

wherein the native tissue is selected from the group consisting of dermis, artery, vein, pericardium, heart valve, dura mater, ligament, bone, cartilage, fascia and intestine; and wherein the collagenous tissue matrix is sterile.

2 . The bioremodelable collagenous tissue matrix composition of claim 1 , wherein the collagenous tissue matrix is sterile.

3 . A bioremodelable collagenous tissue matrix composition derived from small intestine, comprising: telopeptide collagen;

elastin, wherein elastin is less than 10% of the total composition based on dry weight; and

non-collagenous and non-elastinous components, wherein said components are less than 5% of the total composition based on dry weight; and

wherein the collagenous tissue matrix is free of detergent residues, enzymatic modification, endotoxin and cells and cellular debris.

4 . The bioremodelable collagenous tissue matrix composition of claim 3 , wherein the collagenous tissue matrix is derived from the tunica submucosa of small intestine.

5 . The bioremodelable collagenous tissue matrix composition of claim 3 , wherein the collagenous tissue matrix is chemically cleaned.

6 . The bioremodelable collagenous tissue matrix composition of claim 3 , wherein the collagenous tissue matrix is sterile.

7 . The bioremodelable collagenous tissue matrix composition of claim 3 , wherein the collagenous tissue matrix is layered and bonded together to form multilayer sheets, tubes, or complex shaped prostheses.

8 . The bioremodelable collagenous tissue matrix composition of claim 7 , wherein the collagenous tissue matrix is crosslinked.

Assignments (4)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT Recorded Aug 6, 2021
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 057112/0677 →
SECURITY INTEREST Recorded Jun 19, 2018
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 046392/0242 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2017
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: ORGANOGENESIS INC.
Reel/Frame 042072/0977 →
SECURITY AGREEMENT Recorded Sep 23, 2011
From: ORGANOGENESIS, INC.
To: WELLS FARGO BANK, N.A.
Reel/Frame 026954/0666 →